Form 4: Doximity Director Phoebe L. Yang Watkin Receives Stock Grant

Director Phoebe L. Yang Watkin received 6,360 shares of Doximity Class A Common Stock in the form of restricted stock units (RSUs) on August 29, 2024.

Summary

• On August 29, 2024, Phoebe L. Yang Watkin, a director of Doximity, Inc. (DOCS), was granted 6,360 shares of Class A Common Stock in the form of restricted stock units (RSUs).
• These RSUs were granted pursuant to the Issuer's non-employee director compensation policy.
• The RSUs vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, contingent upon the director's continued service.
• Each RSU represents a contingent right to receive one share of Doximity's Class A Common Stock.
• Following this transaction, Ms. Yang Watkin beneficially owns 17,618 shares of Doximity Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine director compensation event, which is generally neutral to positive as it incentivizes leadership. There are no indications of negative sentiment.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The RSUs will vest on the earlier of the first anniversary of the grant date or the next annual meeting of stockholders, subject to the Reporting Person's continued service as a director.

Industry Context

Stock grants to directors are a common practice to align their interests with those of the shareholders and incentivize them to contribute to the long-term success of the company. This is a standard form 4 filing related to director compensation.

Comparison to Industry Standards

• Director compensation packages, including stock grants, vary across the industry depending on company size, performance, and board responsibilities.
• Comparing Doximity's director compensation to that of similar companies in the healthcare technology sector would provide a better understanding of its competitiveness.
• Companies like Teladoc Health, Veeva Systems, and Cerner Corporation (now Oracle Health) could be considered for benchmarking director compensation practices.

Stakeholder Impact

• The stock grant to the director aligns her interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates